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Abstract
An adequate and timely production of ATP by brain cells is of
cardinal importance to support the major energetic cost of the
rapid processing of information via synaptic and action pot-
entials. Recently, evidence has been accumulated to support
the view that the regulation of brain energy metabolism is un-
der the control of an intimate dialogue between astrocytes and
neurons. In vitro studies on cultured astrocytes and in vivo
studies on rodents have provided evidence that glutamate and
Na+ uptake in astrocytes is a key triggering signal regulating
glucose use in the brain. With the advent of NMR spectro-
scopy, it has been possible to provide experimental evidence
to show that energy consumption is mainly devoted to gluta-
matergic neurotransmission and that glutamate-glutamine
cycling is coupled in a  1 : 1 molar stoichiometry to glucose
oxidation, at least in the cerebral cortex. This improved
understanding of neuron–astrocyte metabolic interactions of-
fers the potential for developing novel therapeutic strategies
for many neurological disorders that include a metabolic deficit.
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Activated neurons oxidize more glucose to face their
increased energy need. Until recently, this assertion was the
starting point of any textbook devoted to brain energy
metabolism (Siesjo¨ 1978). During the last decade, the
entrance of astrocytes in the scene of neuroscience has
revolutionized many constrained principles (for review see
Volterra and Meldolesi 2005). As for the other ﬁelds of
neuroscience, astrocytes are now important and active
partners of neurons in the regulation of brain energy
metabolism. Since many comprehensive and authoritative
reviews have already been published on this topic (Ames
2000; Magistretti 2003), we will only underline the mile-
stones that have led to the notion that brain energy
metabolism is regulated by an intimate dialogue between
astrocytes and neurons and speciﬁcally review the major
contribution of Nuclear Magnetic Resonance (NMR)
spectroscopy to this notion. We will ﬁnally discuss the
importance of such a crosstalk during pathological situations.
From blood to ATP: the long journey of glucose
Although the brain represents only 2% of the body weight, it
receives 15% of the cardiac output and accounts for 20% of
total body oxygen consumption, and 25% of total body
glucose utilization. The respiratory quotient (RQ) of the brain
is close to 1, indicating that carbohydrates are the substrates
for oxidative metabolism (for references see Magistretti
2003). However, the brain is also able to use additional
energy substrates if they are present in sufﬁcient amounts in
the blood. For example, the brain can rely on ketone bodies
when their blood levels rise in conditions of prolonged
starvation or high-fat diet (Nehlig 2004). Blood-borne
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glucose crosses the vascular endothelial cells and enters brain
cells through speciﬁc hexose transporters of the glucose
transporter (GLUT) family (Fig. 1), along its diffusion
gradient (Vannucci et al. 1997; McEwen and Reagan
2004). The glucose concentration in the blood is around
5 mM (at normoglycemia) and approximately 1 mM in the
extracellular space (for references see Leybaert 2005).
Besides the 55 kDa GLUT1 which is highly expressed at
luminal and abluminal plasma membranes of blood–brain
barrier endothelial cells, each cell type can express a different
form of GLUTs, suggesting that glucose transport is
differentially regulated among brain cells. Following trans-
port, glucose is phosphorylated by the hexokinase. This
process merits a great attention because it is the rate-limiting
step in glycolysis and as such, it may exert control over
glucose metabolism. However, a recent analysis has sugges-
ted that glucose transport may also be a rate-limiting step for
glucose use (Barros et al. 2005). At rest, the baseline
metabolic rate of the brain is very high and heterogeneous
(Gusnard and Raichle 2001) and most of the energy
consumed by the brain is thought to support glutamatergic
neurotransmission at least in the cortical grey matter (see
paragraph on NMR spectroscopy) (Shulman et al. 2004).
Physiological changes in the cellular activity of the brain are
invariably accompanied by changes in local blood ﬂow and
glucose utilization. Such powerful relationships formed the
bases for the imaging methods such as Positron Emission
Tomography (PET) and functional Magnetic Resonance
Imaging (fMRI) (Raichle 1998).
In the mid-1980s, brain imaging studies using PET
indicated that in normal, awake adult humans, visual or
somatosensory stimulation results in dramatic increases in
blood ﬂow and glucose utilization but minimal increases in
oxygen consumption. These results supported the dissident
notion that a part of the glucose consumption process during
an increased neuronal activity might be non-oxidative (Fox
and Raichle 1986; Fox et al. 1988). As the supply of oxygen
is therefore not matched precisely with the demand, an
unexpected consequence is that the actual amount of oxygen
remaining in blood vessels at the site of brain activation
Fig. 1 Neurotransmitter cycling and metabolic fluxes between neu-
rons and astrocytes. Glutamatergic neurotransmission is governed
both by the action of glutamate (Glu) upon postsynaptic glutamate
receptors (Glu-R) following its release into the synaptic cleft and by the
uptake of glutamate by astrocytes via excitatory amino acid trans-
porters (EAAT). In astrocytes, glutamate is converted into glutamine
(Gln) by glutamine synthetase (GS). Glutamine is then transported
back to neurons and transformed into glutamate by the phosphate-
activated glutaminase (PAG). This specific cellular localization of
these transporters and enzymes allows to define a neuronal pool
of glutamate and an astrocytic pool of glutamine. The quantification of
energy metabolism by NMR essentially relies on the detection of 13C
accumulation within these two large cerebral pools. Indeed, following
injection of 13C-enriched glucose, 13C labeling is incorporated through
complete metabolic pathways, including transport via glucose trans-
porters (Glut1–55: glucose transporter 1, endothelial, 55Kd isoform;
Glut1–45: glucose transporter 1, astrocytic, 45Kd isoform; Glut3: glu-
cose transporter 3, neuronal), glycolysis, neuronal TCA cycle (through
pyruvate dehydrogenase, PDH via acetylCoA, AcCoa) and astrocytic
TCA cycle (through PDH and Pyruvate Carboxylase, PC). Since the
pool of alpha-ketoglutarate (a-KG) is dynamically equilibrated with the
pool of glutamate, different fluxes (filled arrows) can be determined:
the neuronal and astrocytic TCA cycle flux (VTCA), the pyruvate
carboxylase flux (VPC) and the glutamate/glutamine cycle flux (Vcycle).
Due to the low sensitivity of NMR detection and since no compart-
mentation exists for lactate, it is currently not possible to quantify
neither the glycolytic flux nor the astrocyte-neuron lactate shuttle (grey
arrows) with in vivo NMR spectroscopy.
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changes. Because the MRI signal intensity is sensitive to the
amount of oxygen carried by hemoglobin (Ogawa et al.
1990), this change in blood oxygen content at the site of
brain activation formed the basis for the blood-oxygen-level-
dependent signal that is now routinely employed in many
imaging institutes (Raichle 1998). To summarize, in physio-
logical conditions, glucose is the sole substrate for energy
production and it is broken down with the help of oxygen to
supply the brain with energy. During neuronal activation,
glucose may be broken down anaerobically, by the rapid
process of glycolysis, to supply energy faster (Gusnard and
Raichle 2001). In the next section (vide infra), we will shed
light upon the notion that glutamate plays a key role in the
regulation of brain energy metabolism through neuron–
astrocyte interactions.
Glutamate: from glucose to synaptic vesicles, a
process controlled by astrocytes
Glutamate, the major excitatory transmitter in many brain
regions including the cortex, possesses several characteristics
that make it a unique neurotransmitter in the ﬁeld of
neuroenergetics (see Magistretti 2003). On one hand, it is
tightly linked to the metabolism of glucose and on the other
hand, glutamate represents a coupling signal to supply active
neurons with glucose-derived energy.
Glutamate is an alpha-ketoglutarate [a-KG, an intermedi-
ate of the tricarboxylic acid (TCA) cycle] derivative and its
pool is dynamically equilibrated with the pool of a–KG via a
bidirectional transamination (Fig. 1) so that glutamate can be
labeled following in vivo administration of any labeled
substrate that will enter the TCA cycle (see paragraph on
NMR spectroscopy). Glutamate is also a metabolic fuel since
it can be oxidatively degraded, after its conversion to a-KG
(Waagepetersen et al. 2002), to provide up to three-fourths of
the ATP that glucose oxidation can produce (for references
see Hertz and Zielke 2004; Marcaggi and Attwell 2004).
Such an oxidation process is supposed to occur mainly in
astrocytes.
Following release in the synaptic cleft, glutamate is avidly
taken up by astrocytes to start an ‘ecological’ process of
recycling. Indeed, glutamate re-uptake is efﬁciently per-
formed by two glial glutamate transporters (EAAT1 or
GLAST and EAAT2 or GLT-1) (Danbolt 2001) while the
conversion of glutamate into glutamine is under the control
of a speciﬁc astrocytic enzyme, glutamine synthetase (GS).
Glutamine is then transported back to neurons via amino acid
transporters (Mackenzie and Erickson 2004), then trans-
formed into glutamate by the phosphate-activated glutami-
nase and ﬁnally packed into vesicles by the vesicular
glutamate transporters (Fremeau et al. 2004) (Fig. 1). There-
fore, the levels of glutamate available to neuronal vesicles are
dependent upon astrocyte delivery (in the form of glutamine).
The cost of the glutamate recycling is two ATP for each
recycled molecule (one ATP for the NA/K ATPase and one
ATP for the GS).
Because glutamate can be oxidized and is not fully
regenerated through the glutamate-glutamine cycle, its
de novo synthesis is required to maintain the neuronal
glutamate pool. This synthesis requires the major metabolic
fuel glucose to provide the carbon backbone as a-KG
through the TCA cycle. Since a-KG is used for this synthesis
and in order to maintain the TCA ﬂux, a net synthesis of
TCA intermediates must occur. This is performed by the
enzyme pyruvate carboxylase (PC) which generate oxaloac-
etate and is located almost exclusively in astrocytes (Hertz
and Zielke 2004) (Fig. 1).
In conclusion, glutamate is a signaling molecule for
excitatory transmission when acting upon neuronal/glial
receptors but since its synthesis is closely linked to glucose
metabolism, glutamate may also be involved in the regula-
tion of brain energy metabolism. Experiments performed
12 years ago on cell cultures have indeed demonstrated that
glutamate may be a coupling signal between neuronal
activity and glucose uptake (Pellerin and Magistretti 1994).
Glutamate/Na+ uptake into astrocytes: a key triggering
signal for glucose use
The precise molecular mechanisms responsible for the
increase in glucose use by the active brain cells have
remained unclear until recently. Results obtained from in vivo
studies have indicated that the increase in glucose use varies
in proportion to the magnitude of neuronal activity (Sokoloff
1999). Neuronal excitation generates action potentials pro-
duced by a depolarization-induced rapid inward Na+ current
and K+ efﬂux. Numerous experiments have been conducted
in cell cultures to determine the effects of elevated extracel-
lular K+ and/or intracellular Na+ on glucose metabolism. In
cultured neurons, membrane depolarization by elevated
extracellular K+ concentration causes rapid Na+ inﬂux
through voltage-sensitive Na+ channels. The consequent
increases in intracellular Na+ concentration and/or extracel-
lular K+ stimulate Na+, K+-ATPase activity, which in turn
stimulates energy metabolism and the rate of glucose
utilization in neurons (Takahashi et al. 1995). The direct
increase of intracellular Na+ by opening voltage-sensitive
Na+ channels with veratridine also stimulates neuronal
glucose uptake (Takahashi et al. 1995; Honegger and Pardo
1999). In contrast, astrocytic glucose metabolism is not
stimulated by high extracellular K+, since these cells do not
produce action potential and, indeed, have a large capability
to buffer K+ (Seifert et al. 2006). However, glucose meta-
bolism is stimulated by increased intracellular Na+ in
astrocytes as in neurons. Na+-mediated stimulation of
glucose use can be triggered by the carboxylic Na+ ionophore
monensin (Yarowsky et al. 1986), by veratridine (Takahashi
et al. 1995), also by cyclothiazide which prevents desensi-
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tization of AMPA receptors thereby increasing Na+ inﬂux
(Chatton et al. 2000; Voutsinos-Porche et al. 2003b) and
ﬁnally by the cognitive-enhancing drug CX546 that increases
Na+ inﬂux through AMPA receptors (Pellerin and Magistretti
2005).
Apart from depolarization and ionic ﬂuxes, neurotrans-
mission also involves release of speciﬁc neurotransmitters
such as glutamate. Indeed, the presence of glutamate itself
can raise glucose uptake in astrocytes in a dose-dependent
manner (Pellerin and Magistretti 1994; Takahashi et al.
1995). The effect of glutamate is mediated by the Na+-
dependent glutamate uptake system in astrocytes (GLAST
and GLT-1) independently of glutamate receptors, which may
provide a new mechanism of neurometabolic coupling.
Glutamate uptake is powered by the cotransport of three Na+
ions and one H+ while one K+ is counter-transported (Attwell
and Gibb 2005). Additional experiments have conﬁrmed that
it is indeed the intracellular concentration of Na+ and not
glutamate itself that activates the Na+, K+-ATPase pump,
decreases ATP levels and activates glycolysis in astrocytes
(Chatton et al. 2000; Voutsinos-Porche et al. 2003b) upon
glutamate release. Results from experiments performed
in vivo have supported such hypothesis by showing that
the glucose use evoked by either somatosensory (Voutsinos-
Porche et al. 2003a; Voutsinos-Porche et al. 2003b) or visual
stimulation (Herard et al. 2005) is strongly decreased in mice
deﬁcient for GLT-1. Owing to the fact that astrocytes are
highly connected cells through gap junctions (Giaume and
McCarthy 1996), it has been recently proposed that astro-
cytes function as a network for concerted neurometabolic
coupling through the generation of intercellular Na+ meta-
bolic waves (Bernardinelli et al. 2004). However, it is
important to consider that the uptake of glutamate per se does
not consume energy and that only the associated glutamine
synthesis and reestablishment of the Na+ gradient will use
ATP (no more than 3% of the total ATP consumed, see
Attwell and Laughlin 2001).
Besides stimulation of glycolysis in astrocytes, can
glutamate also regulate the transport of glucose in both
neurons and astrocytes? To address this question, glucose
transport was studied simultaneously in cultured hippocam-
pal neurons and neighboring astrocytes using a real-time
assay based on confocal epiﬂuorescence microscopy and
ﬂuorescent glucose analogs (Porras et al. 2004). These
authors found that glutamate, although stimulating glucose
transport in astrocytes, strongly inhibited glucose transport in
neurons, by a mechanism that is dependant on glutamate
receptors. These results suggest that glutamate is not only
able to activate astrocytic glycolysis but could also differ-
entially regulate glucose transport in astrocytes and neurons.
If there is a consensus about the notion that the entry of
Na+, which is related, via a close stoichiometry, to the uptake
of glutamate in astrocytes, is a key signaling metabolic event,
a strong controversy still exists about the existence of a
metabolic compartmentalization between glycolytic astro-
cytes and oxidative neurons (see for references Bonvento
et al. 2005). The hypothesis initially put forward by Pellerin
and Magistretti was that, upon glutamate release, astrocytes
will export lactate to the neurons where it is converted back
to pyruvate in order to fuel mitochondria (Pellerin and
Magistretti 1994). The controversy over this so called
astrocyte neuron lactate shuttle is not the topic of the current
review and many recent reviews have been already published
(Hertz 2004; Bonvento et al. 2005; Schurr 2006).
We will now discuss how results obtained by NMR
spectroscopy have provided convincing arguments in favor
of a central role of astrocytes and glutamate in the regulation
of brain metabolism.
Astrocyte contribution to the regulation of energy
metabolism as revealed in vivo by 13C NMR
spectroscopy
Intimacy of astrocytes/neurons dialogue partially
undisclosed by NMR
Since the mid-1980s, NMR spectroscopy has proven a
unique tool to measure brain metabolic ﬂuxes in vivo. The
most common NMR approach relies on the infusion of 13C-
enriched substrates of brain metabolism, mainly glucose but
occasionally acetate or ketone bodies. The natural abundance
of 13C being 1.1%, isotopic incorporation into brain meta-
bolites can be measured during i.v. infusion of highly
13C-enriched substrates (Rothman et al. 1985). The 13C
measurement of metabolic rates has strong similarities with
radio-isotopic imaging techniques such as 14C-2-DG autora-
diography or 18F-FDG-PET which measure glucose con-
sumption (Boumezbeur et al. 2005). However the NMR
approach differs from radiotracer detection in several ways
and may advocate NMR as the instrument of choice for
in vivo monitoring of the dialogue between astrocytes and
neurons.
NMR spectroscopy has the unique property to speciﬁcally
identify the molecule and the atomic position in this
molecule at which the 13C label accumulates. This contrasts
with nuclear techniques for which radioactivity is measured,
independently of the metabolite the radioactive tracer is
attached to. Thanks to this property, fully metabolized
substrates, i.e. [1–13C]glucose, that are metabolized the same
way as endogenous non-labeled substrates, can be used. In
contrast, radio-isotopic techniques like PET or autoradio-
graphy must use non-metabolizable analogs like 18F-FDG or
14C-2-DG to measure glucose use following acquisition of a
single time-activity curve originating from all radio-labeled
atomic positions.
13C-NMR provides several 13C time-courses for identiﬁed
carbon positions, supplying sufﬁcient information to use
complex metabolic models to derive metabolic ﬂuxes
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including all major pathways labeled by 13C-glucose. Indeed,
upon i.v. administration of [1–13C]glucose, 13C is incorpor-
ated into glycolysis, neuronal TCA cycle (through pyruvate
dehydrogenase, PDH), astrocytic TCA cycle (through PDH
and PC), and substrate exchange between neurons and
astrocytes (glutamate/glutamine cycle, see Fig. 1). In vivo
NMR performed during [1–13C]glucose administration
allows to distinguish 13C accumulation within 10 different
atomic positions in different molecules: glutamate C2, C3
and C4, glutamine C2, C3 and C4, glucose C1, lactate C3,
aspartate C2 and C3 (Behar et al. 1986), glutamine (Gruetter
et al. 1994; Gruetter et al. 2001) and to a lesser extent
aspartate or glycogen (Choi et al. 1999). In particular, the
possibility to resolve glutamate labeling from glutamine
labeling is of great interest for the study of the dialogue
between astrocytes and neurons. Indeed, glutamate and
glutamine are strongly compartmentalized (in neurons for
glutamate and in astrocytes for glutamine) and they are
directly connected to energy metabolism and neurotransmis-
sion (see former paragraph).
These two features of 13C NMR have allowed quantitative
determination of ﬂuxes through energy metabolism and
neurotransmission in rat and human cerebral cortex. Using
neuron/astrocyte bi-compartment models (Sibson et al.
1997; Shen et al. 1999; Gruetter et al. 2001) ﬂuxes within
each cell type and ﬂuxes connecting both cell populations
were determined: the neuronal and astrocytic TCA cycle ﬂux
(VTCA), the pyruvate carboxylase ﬂux (VPC) and the
glutamate/glutamine cycle ﬂux (Vcycle) (Fig. 1). Those early
studies – based on [1–13C]glucose – were shortly followed
by alternate labeling strategies using [2–13C]glucose or
[2–13C]acetate which provided independent measures with
increased sensitivity to particular pathways (anaplerosis for
[2–13C]glucose, astrocytic TCA cycle for [2–13C]acetate)
(Sibson et al. 2001; Lebon et al. 2002). All studies yielded
consistent values, demonstrating that the glutamate/gluta-
mine cycle is a major metabolic ﬂux in the mammalian brain,
and that glutamate neurotransmitter replenishment is essen-
tially accomplished by the neuron/astrocyte glutamate/gluta-
mine cycle. The glutamate/a-KG cycle was shown to account
for less than 10% of substrate cycling between astrocytes and
neurons (Lebon et al. 2002). By unambiguously demonstra-
ting the crucial role of astrocytes in maintaining the synaptic
homeostasis of glutamate, these 13C NMR studies brought a
signiﬁcant contribution to the understanding of the neuron/
astrocyte dialogue.
The second major contribution results from the unique
ability of NMR to derive both the rate of glucose oxidation
(VTCA) and the rate of neurotransmission (Vcycle) from the
13C time-courses collected during the same experiment.
About 20 years before NMR made it possible to measure
those two metabolic rates in vivo, 14C-2-DG studies demon-
strated that glucose metabolism and electrical activity were
tightly coupled in regions rich in synapses but not in cell
bodies (see for references Sokoloff 1999). These observa-
tions supported the concept of coupling between energy
metabolism and neurotransmission. From the mid-1990s,
NMR allowed in vivo exploration of the relationship between
glucose consumption and neurotransmission in rodents at
different levels of electrical activity (Sibson et al. 1998; Choi
et al. 2002; Oz et al. 2004; Patel et al. 2004) and in various
brain regions (de Graaf et al. 2004). Altogether these studies
demonstrated a roughly linear relationship between glucose
oxidation and neurotransmission in the rat brain. In spite of
controversies on the value of glucose consumption at
isoelectricity (intercept of the ‘neurotransmission – glucose
oxidation’ curve) and on the exact slope of the relationship
(Choi et al. 2002; Gruetter 2002), 13C NMR studies provided
strong evidence to suggest that energy consumption is mostly
devoted to neurotransmission in the cerebral cortex, and that
changes in neurotransmission result in proportional changes
in glucose metabolism (Hyder et al. 2006). At the same time,
independent in vitro studies on cultured astrocytes and
ex vivo studies on rodents suggested that astrocytic glutamate
uptake may regulate energy metabolism. In this context,
the NMR-observed relationship between glucose oxidation
and glutamate/glutamine neurotransmission cycling brings
strong arguments in favor of a tight coupling, in vivo,
between neuronal activity and energy metabolism medi-
ated by glutamate transport from the synaptic cleft into
astrocytes.
Large parts of the conversation remain undisclosed
13C NMR presents several striking advantages over radio-
tracer techniques for the exploration of brain energy
metabolism, mostly due to the NMR signal reﬂecting the
molecular environment of each detected nucleus. But the
price for this ﬁne biochemical probing is the intrinsic low
sensitivity of NMR detection. A practical consequence is the
inability to detect trace amounts of the label by NMR.
Quantiﬁcation of energy metabolism by NMR essentially
relies on the detection of 13C accumulation within the large
cerebral pools of glutamate (10 mM) and glutamine
(3 mM). The fact that 13C label undergoes glycolysis does
not imply that the glycolytic ﬂux can be determined by
NMR, simply because the concentration of glycolytic
intermediates is far too low to be detected by 13C NMR,
even when it becomes highly enriched. Notwithstanding, if
glycolytic intermediates could be detected by 13C NMR, the
absence of clear compartmentation of lactate would not allow
NMR spectroscopy to assign a glycolytic ﬂux to any cell
type. Therefore in vivo NMR is currently unable to resolve
the controversy on the existence of a lactate shuttle.
Although in vitro and ex vivo NMR studies do not allow
quantitative measurements of metabolic ﬂuxes, they can offer
experimental arguments in favor of a preferential lactate
consumption by neurons. Performing NMR spectroscopy on
cell cultures has several advantages over in vivo NMR:
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speciﬁc cell types can be studied (astrocytes or neurons), 13C
precursors that barely cross the BBB can be used, and
increased sensitivity can be achieved by high resolution
NMR analysis of cell suspensions. Based on this approach,
evidence for lactate being preferentially metabolized by
neurons has accumulated (Waagepetersen et al. 2000a;
Bouzier-Sore et al. 2003) and the concept of a lactate/
alanine shuttle between astrocytes and neurons was proposed
(Waagepetersen et al. 2000b; Zwingmann et al. 2000;
Zwingmann and Leibfritz 2003). Through this shuttle,
alanine would be a nitrogen carrier from glutamatergic
neurons to astrocytes, providing astrocytes with nitrogen for
glutamine synthesis. Lactate would provide neurons with
carbon chains for oxidation. Ex vivo 13C NMR – which
consists in high resolution analysis of brain extracts labeled
in vivo – also supported the existence of a signiﬁcant lactate
ﬂux from astrocytes to neurons. Using combinations of 13C-
labeled and unlabeled glucose and lactate administered
in vivo, the implication of the astrocyte-neuron lactate shuttle
in the coupling between cerebral activity and energy
metabolism has been demonstrated (Serres et al. 2003;
2005). In vivo observation of the lactate/alanine shuttle and
quantiﬁcation of the lactate ﬂux from astrocytes to neurons
are beyond the current sensitivity of in vivo NMR. The
question as to whether high ﬁeld in vivo NMR system will
help resolving these issues remains open.
Another consequence ofNMR intrinsic low sensitivity is the
need to perform 13C NMRmeasurements in large brain voxels
(typically25 mL in humans) which are two to three orders of
magnitude larger than the spatial resolution of human PET
systems (0.1 mL). For rodent studies, high-ﬁeld NMR
systems signiﬁcantly reduce the gap. Indeed the NMR signal
increases with the magnetic ﬁeld (due to increased spin
polarization), whereas the radiotracer activity does not
increase when reducing the size of the PET system. However,
the typical spatial resolution of 13C detection in rats (50 lL)
remains larger than micro-PET (5 lL) by one order of
magnitude. This is the main reason why 13C NMR has been
having a hard time exploring focal neural activation, whereas
PET studies provided convincing data on the energy basis of
cerebral activation (Fox et al. 1988). Several groups have
attempted to quantify changes in oxidative metabolism
associated with focal activation (Hyder et al. 1996; Chen
et al. 2001; Chhina et al. 2001). However the sensitivity of
in vivoNMR is limited for the accurate quantiﬁcation of energy
metabolism and neurotransmission upon focal activation. It
must be noted that the exploration of the coupling between
neurotransmission and energy metabolism was not performed
by varying the degree of focal neural activation, but by
modulating whole brain activity using various anesthetics.
This observation does not minimize the interest of this
landmark work, but studying the relationship between neuro-
transmission and energy metabolism upon focal neural acti-
vation remains a challenge for 13C NMR spectroscopy.
In the last section, we will brieﬂy point out the potential
relevance of this metabolic crosstalk between neurons and
astrocytes during various pathological conditions.
Neuron–astrocyte metabolic interactions during
pathological conditions
The brain, which has important energy needs and low
glycogen levels [located in astrocytes (see Brown 2004)], is
highly vulnerable to energetic dysfunction. Many brain
diseases have an energetic component (Beal 2000) but the
role of the metabolic impairment in the disease process is
highly variable. It can be very straightforward as during a
stroke when the acute disruption in energy supply will lead to
a massive cellular death in the infarct core (Lo et al. 2003).
In some genetic diseases, the mutation of a key metabolic
enzyme or transporter (ex: GLUT1 deﬁciency syndrome, see
Wang et al. 2005) triggers neuronal dysfunction. Alternat-
ively, the impact of metabolic impairment in the disease
process can be indirect and exacerbate other pathological
events such as reactive oxygen species production, calcium
deregulation and in particular glutamate excitotoxicity (Beal
2000). Many reviews have addressed the deleterious role of
metabolic impairment during pathogenic processes. How-
ever, the focus is usually on one partner (neurons) and the
impact of a dysfunctional dialogue between astrocytes and
neurons has been underestimated until recently (Seifert et al.
2006).
Given the key role played by glutamate in the regulation of
brain energy metabolism and the fact that glutamatergic
homeostasis is maintained through exchanges between
astrocytes and neurons, any deregulation of this dialogue is
likely to induce combined (and potentially additive) dele-
terious effects for brain function. In addition, glutamate can
by itself be neurotoxic. If present at too high concentration in
the synaptic cleft, it is a potential neurotoxin and can trigger
neuronal death by a process called excitotoxicity. During
stroke, glutamate is massively released from synaptic
vesicles and from cytoplasmic pools through transporters
working in a reverse mode (Jabaudon et al. 2000; Rossi
et al. 2000), and different types of transmembrane channels
(see References in (Volterra and Meldolesi 2005). The
reversal of glutamate transporters not only hampers the
removal of glutamate from the extracellular space, it also
exacerbates the shortage in energetic substrates by suppres-
sing the coupling signal for glucose entry into brain
parenchyma. A dysfunction of the homeostasis, recycling
and metabolism of glutamate is also involved during the
course of many chronic neurodegenerative diseases. Abnor-
malities in glutamate homeostasis and metabolic function are
both hallmarks of neurodegenerative diseases such as
Parkinson’s disease, Alzheimer’s disease, Huntington’s dis-
ease and amyotrophic lateral sclerosis (ALS) (Maragakis and
Rothstein 2004). In ALS patients for example, the regions of
selective death of motoneurons (spinal cord and motor
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cortex) have a lower capacity for glutamate uptake (Rothstein
et al. 1992) and express GLT-1 at a reduced level (Rothstein
et al. 1995). Again, a reduction in glutamate uptake would
lead to excitotoxicity but would also reduce glucose supply
and exacerbate energy impairment. Increasing the level of
expression of glutamate transporters with b-lactam has
proven an efﬁcient therapeutic approach in ALS. This drug
delayed neuronal loss and muscle strength and increased
mouse survival in an animal model of ALS (Rothstein et al.
2005).
Such a strategy could also improve brain energetic supply
by bolstering the signal for glucose uptake. More generally,
reinforcing the efﬁciency of the metabolic dialogue between
neurons and astrocytes may be beneﬁcial for neuronal
survival. Indeed, it has recently been shown that a viral
vector-driven overexpression of lactate transporters on
neurons and glucose transporters on astrocytes efﬁciently
protects neurons from excitotoxicity in vitro (Bliss et al.
2004).
Acknowledgements
Supported by grants from the CNRS and the CEA. The authors
acknowledge the help of Dr Alan R. Young for a careful reading of
the manuscript.
References
Ames A. and 3rd (2000) CNS energy metabolism as related to function.
Brain Res. Brain Res. Rev. 34, 42–68.
Attwell D. and Gibb A. (2005) Neuroenergetics and the kinetic design of
excitatory synapses. Nat Rev. Neurosci. 6, 841–849.
Attwell D. and Laughlin S. B. (2001) An energy budget for signaling in
the grey matter of the brain. J. Cereb Blood Flow Metab 21, 1133–
1145.
Barros L. F., Porras O. H. and Bittner C. X. (2005) Why glucose
transport in the brain matters for PET. Trends Neurosci. 28, 117–
119.
Beal M. F. (2000) Energetics in the pathogenesis of neurodegenerative
diseases. Trends Neurosci. 23, 298–304.
Behar K. L., Petroff O. A., Prichard J. W., Alger J. R. and Shulman R. G.
(1986) Detection of metabolites in rabbit brain by 13C NMR
spectroscopy following administration of [1–13C]glucose. Magn
Reson Med. 3, 911–920.
Bernardinelli Y., Magistretti P. J. and Chatton J. Y. (2004) Astrocytes
generate Na+-mediated metabolic waves. Proc. Natl Acad. Sci.
USA 101, 14 937–14 942.
Bliss T. M., Ip M., Cheng E., Minami M., Pellerin L., Magistretti P. and
Sapolsky R. M. (2004) Dual-gene, dual-cell type therapy against an
excitotoxic insult by bolstering neuroenergetics. J. Neurosci. 24,
6202–6208.
Bonvento G., Herard A. S. and Voutsinos-Porche B. (2005) The astro-
cyte-neuron lactate shuttle: a debated but still valuable hypothesis
for brain imaging. J Cereb Blood Flow Metab 25, 1394–1399.
Boumezbeur F., Besret L., Valette J et al. (2005) Glycolysis versus TCA
cycle in the primate brain as measured by combining 18F-FDG
PET and 13C-NMR. J. Cereb Blood Flow Metab 25, 1418–1423.
Bouzier-Sore A. K., Voisin P., Canioni P., Magistretti P. J. and Pellerin L.
(2003) Lactate is a preferential oxidative energy substrate over
glucose for neurons in culture. J. Cereb Blood Flow Metab 23,
1298–1306.
Brown A. M. (2004) Brain glycogen re-awakened. J. Neurochem. 89,
537–552.
Chatton J. Y., Marquet P. and Magistretti P. J. (2000) A quantitative
analysis of 1-glutamate-regulated Na+ dynamics in mouse cortical
astrocytes: implications for cellular bioenergetics. Eur J. Neurosci.
12, 3843–3853.
Chen W., Zhu X. H., Gruetter R., Seaquist E. R., Adriany G. and Ugurbil
K. (2001) Study of tricarboxylic acid cycle ﬂux changes in human
visual cortex during hemiﬁeld visual stimulation using (1) H-[(13)
C] MRS and fMRI. Magn Reson Med. 45, 349–355.
Chhina N., Kuestermann E., Halliday J., Simpson L. J., Macdonald I. A.,
Bachelard H. S. and Morris P. G. (2001) Measurement of human
tricarboxylic acid cycle rates during visual activation by (13) C
magnetic resonance spectroscopy. J. Neurosci. Res. 66, 737–746.
Choi I. Y., Lei H. and Gruetter R. (2002) Effect of deep pentobarbital
anesthesia on neurotransmitter metabolism in vivo: on the corre-
lation of total glucose consumption with glutamatergic action.
J. Cereb Blood Flow Metab 22, 1343–1351.
Choi I. Y., Tkac I., Ugurbil K. and Gruetter R. (1999) Noninvasive
measurements of [1-(13) C]glycogen concentrations and metabo-
lism in rat brain in vivo. J. Neurochem. 73, 1300–1308.
Danbolt N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1–105.
Fox P. T. and Raichle M. E. (1986) Focal physiological uncoupling of
cerebral blood ﬂow and oxidative metabolism during somatosen-
sory stimulation in human subjects. Proc. Natl Acad. Sci. USA 83,
1140–1144.
Fox P. T., Raichle M. E., Mintun M. A. and Dence C. (1988) Nonoxi-
dative glucose consumption during focal physiologic neural
activity. Science 241, 462–464.
Fremeau R. T. Jr, Voglmaier S., Seal R. P. and Edwards R. H. (2004)
VGLUTs deﬁne subsets of excitatory neurons and suggest novel
roles for glutamate. Trends Neurosci. 27, 98–103.
Giaume C. and McCarthy K. D. (1996) Control of gap-junctional
communication in astrocytic networks. Trends Neurosci. 19, 319–
325.
de Graaf R. A., Mason G. F., Patel A. B., Rothman D. L. and Behar K. L.
(2004) Regional glucose metabolism and glutamatergic neuro-
transmission in rat brain in vivo. Proc. Natl Acad. Sci. USA 101,
12 700–12 705.
Gruetter R. (2002) In vivo 13C NMR studies of compartmentalized
cerebral carbohydrate metabolism. Neurochem. Int. 41, 143–154.
Gruetter R., Novotny E. J., Boulware S. D., Mason G. F., Rothman D.
L., Shulman G. I., Prichard J. W. and Shulman R. G. (1994)
Localized 13C NMR spectroscopy in the human brain of amino
acid labeling from D-[1–13C]glucose. J. Neurochem. 63, 1377–
1385.
Gruetter R., Seaquist E. R. and Ugurbil K. (2001) A mathematical model
of compartmentalized neurotransmitter metabolism in the human
brain. Am. J. Physiol. Endocrinol. Metab 281, E100–E112.
Gusnard D. A. and Raichle M. E. (2001) Searching for a baseline:
functional imaging and the resting human brain. Nat Rev. Neurosci.
2, 685–694.
Herard A. S., Dubois A., Escartin C., Tanaka K., Delzescaux T.,
Hantraye P. and Bonvento G. (2005) Decreased metabolic re-
sponse to visual stimulation in the superior colliculus of mice
lacking the glial glutamate transporter GLT-1. Eur J. Neurosci.
22, 1807–1811.
Hertz L. (2004) The astrocyte-neuron lactate shuttle: a challenge of a
challenge. J. Cereb Blood Flow Metab 24, 1241–1248.
Hertz L. and Zielke H. R. (2004) Astrocytic control of glutamatergic
activity: astrocytes as stars of the show. Trends Neurosci. 27, 735–
743.
Neuron–astrocyte interaction in brain energy 399
 2006 The Authors
Journal Compilation  2006 International Society for Neurochemistry, J. Neurochem. (2006) 99, 393–401
Honegger P. and Pardo B. (1999) Separate neuronal and glial Na+,K+-
ATPase isoforms regulate glucose utilization in response to mem-
brane depolarization and elevated extracellular potassium. J. Cereb
Blood Flow Metab 19, 1051–1059.
Hyder F., Chase J. R., Behar K. L., Mason J. F., Sideek M., Rothman
D. L. and Shulman R. G. (1996) Increased tricarboxylic acid cycle
ﬂux in rat brain during forepaw stimulation detected with
1H[13C]NMR. Proc. Natl Acad. Sci. USA 93, 7612–7617.
Hyder F., Patel A. B., Gjedde A., Rothman D. L., Behar K. L. and
Shulman R. G. (2006) Neuronal-glial glucose oxidation and
glutamatergic-GABAergic function. J Cereb Blood Flow Metab.
Jabaudon D., Scanziani M., Gahwiler B. H. and Gerber U. (2000) Acute
decrease in net glutamate uptake during energy deprivation. Proc.
Natl Acad. Sci. USA 97, 5610–5615.
Lebon V., Petersen K. F., Cline G. W., Shen J., Mason G. F., Dufour S.,
Behar K. L., Shulman G. I. and Rothman D. L. (2002) Astroglial
contribution to brain energy metabolism in humans revealed by
13C nuclear magnetic resonance spectroscopy: elucidation of the
dominant pathway for neurotransmitter glutamate repletion and
measurement of astrocytic oxidative metabolism. J. Neurosci. 22,
1523–1531.
Leybaert L. (2005) Neurobarrier coupling in the brain: a partner of
neurovascular and neurometabolic coupling? J. Cereb Blood Flow
Metab 25, 2–16.
Lo E. H., Dalkara T. and MoskowitZ. M. A. (2003) Mechanisms,
challenges and opportunities in stroke. Nat Rev. Neurosci. 4, 399–
415.
Mackenzie B. and Erickson J. D. (2004) Sodium-coupled neutral amino
acid (System N/A) transporters of the SLC38 gene family. Pﬂugers
Arch. 447, 784–795.
Magistretti P. (2003) Brain energy metabolism. In: Fundamental
Neuroscience, 2nd edn. (Squire, L., ed.), pp. 339–360. Academic
Press, New York.
Maragakis N. J. and Rothstein J. D. (2004) Glutamate transporters:
animal models to neurologic disease. Neurobiol. Dis 15, 461–473.
Marcaggi P. and Attwell D. (2004) Role of glial amino acid transporters
in synaptic transmission and brain energetics. Glia 47, 217–225.
McEwen B. S. and Reagan L. P. (2004) Glucose transporter expression
in the central nervous system: relationship to synaptic function.
Eur J. Pharmacol. 490, 13–24.
Nehlig A. (2004) Brain uptake and metabolism of ketone bodies in
animal models. Prostaglandins Leukot Essent Fatty Acids 70, 265–
275.
Ogawa S., Lee T. M., Kay A. R. and Tank D. W. (1990) Brain magnetic
resonance imaging with contrast dependent on blood oxygenation.
Proc. Natl Acad. Sci. USA 87, 9868–9872.
Oz G., Berkich D. A., Henry P. G., Xu Y., LaNoue K., Hutson S. M. and
Gruetter R. (2004) Neuroglial metabolism in the awake rat brain:
CO2 ﬁxation increases with brain activity. J. Neurosci. 24, 11 273–
11 279.
Patel A. B., de Graaf R. A., Mason G. F., Kanamatsu T., Rothman D. L.,
Shulman R. G. and Behar K. L. (2004) Glutamatergic neuro-
transmission and neuronal glucose oxidation are coupled during
intense neuronal activation. J. Cereb Blood Flow Metab 24, 972–
985.
Pellerin L. and Magistretti P. J. (1994) Glutamate uptake into astrocytes
stimulates aerobic glycolysis: a mechanism coupling neuronal
activity to glucose utilization. Proc. Natl. Acad. Sci. USA. 91,
10 625–10 629.
Pellerin L. and Magistretti P. J. (2005) Ampakine CX546 bolsters
energetic response of astrocytes: a novel target for cognitive-
enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-is-
oxazolepropionic acid (AMPA) receptor modulators. J. Neuro-
chem. 92, 668–677.
Porras O. H., Loaiza A. and Barros L. F. (2004) Glutamate mediates
acute glucose transport inhibition in hippocampal neurons.
J. Neurosci. 24, 9669–9673.
Raichle M. E. (1998) Behind the scenes of functional brain imaging: a
historical and physiological perspective. Proc. Natl Acad. Sci. USA
95, 765–772.
Rossi D. J., Oshima T. and Attwell D. (2000) Glutamate release in severe
brain ischaemia is mainly by reversed uptake. Nature 403, 316–
321.
Rothman D. L., Behar K. L., Hetherington H. P., den Hollander J. A.,
Bendall M. R., Petroff O. A. and Shulman R. G. (1985) 1H-Ob-
serve/13C-decouple spectroscopic measurements of lactate and
glutamate in the rat brain in vivo. Proc. Natl Acad. Sci. USA 82,
1633–1637.
Rothstein J. D., Martin L. J. and Kuncl R. W. (1992) Decreased glu-
tamate transport by the brain and spinal cord in amyotrophic lateral
sclerosis. N Engl. J. Med. 326, 1464–1468.
Rothstein J. D., Patel S., Regan M. R. et al. (2005) Beta-lactam anti-
biotics offer neuroprotection by increasing glutamate transporter
expression. Nature 433, 73–77.
Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J. and Kuncl
R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in
amyotrophic lateral sclerosis. Ann. Neurol. 38, 73–84.
Schurr A. (2006) Lactate: the ultimate cerebral oxidative energy sub-
strate? J. Cereb Blood Flow Metab 26, 142–152.
Seifert G., Schilling K. and Steinhauser C. (2006) Astrocyte dysfunction
in neurological disorders: a molecular perspective. Nat Rev. Neu-
rosci. 7, 194–206.
Serres S., Bezancon E., Franconi J. M. and Merle M. (2005) Ex vivo
NMR study of lactate metabolism in rat brain under various de-
pressed states. J. Neurosci. Res. 79, 19–25.
Serres S., Bouyer J. J., Bezancon E., Canioni P. and Merle M. (2003)
Involvement of brain lactate in neuronal metabolism. NMR Biomed
16, 430–439.
Shen J., Petersen K. F., Behar K. L., Brown P., Nixon T. W., Mason
G. F., Petroff O. A., Shulman G. I., Shulman R. G. and Rothman
D. L. (1999) Determination of the rate of the glutamate/glutamine
cycle in the human brain by in vivo 13C NMR. Proc. Natl Acad.
Sci. USA 96, 8235–8240.
Shulman R. G., Rothman D. L., Behar K. L. and Hyder F. (2004)
Energetic basis of brain activity: implications for neuroimaging.
Trends Neurosci. 27, 489–495.
Sibson N. R., Dhankhar A., Mason G. F., Behar K. L., Rothman D. L.
and Shulman R. G. (1997) In vivo 13C NMR measurements of
cerebral glutamine synthesis as evidence for glutamate-glutamine
cycling. Proc. Natl Acad. Sci. USA 94, 2699–2704.
Sibson N. R., Dhankhar A., Mason G. F., Rothman D. L., Behar K. L.
and Shulman R. G. (1998) Stoichiometric coupling of brain glu-
cose metabolism and glutamatergic neuronal activity. Proc. Natl
Acad. Sci. USA 95, 316–321.
Sibson N. R., Mason G. F., Shen J., Cline G. W., Herskovits A. Z., Wall
J. E., Behar K. L., Rothman D. L. and Shulman R. G. (2001) In
vivo (13) C NMR measurement of neurotransmitter glutamate
cycling, anaplerosis and TCA cycle ﬂux in rat brain during.
J. Neurochem. 76, 975–989.
Siesjo¨ B. (1978) Brain Energy Metabolism, p. 607. Wiley, New York.
Sokoloff L. (1999) Energetics of functional activation in neural tissues.
Neurochem. Res. 24, 321–329.
Takahashi S., Driscoll B. F., Law M. J. and Sokoloff L. (1995) Role of
sodium and potassium ions in regulation of glucose metabolism in
cultured astroglia. Proc. Natl. Acad. Sci. U.S.A. 92, 4616–4620.
Vannucci S. J., Maher F. and Simpson I. A. (1997) Glucose transporter
proteins in brain: delivery of glucose to neurons and glia. Glia 21,
2–21.
400 C. Escartin et al.
Journal Compilation  2006 International Society for Neurochemistry, J. Neurochem. (2006) 99, 393–401
 2006 The Authors
Volterra A. and Meldolesi J. (2005) Astrocytes, from brain glue to
communication elements: the revolution continues. Nat Rev. Neu-
rosci. 6, 626–640.
Voutsinos-Porche B., Bonvento G., Tanaka K., Steiner P., Welker E.,
Chatton J. Y., Magistretti P. J. and Pellerin L. (2003b) Glial Glu-
tamate Transporters Mediate a Functional Metabolic Crosstalk
between Neurons and Astrocytes in the Mouse Developing Cortex.
Neuron 37, 275–286.
Voutsinos-Porche B., Knott G., Tanaka K., Quairiaux C., Welker E.
and Bonvento G. (2003a) Glial glutamate transporters and
maturation of the mouse somatosensory cortex. Cereb Cortex 13,
1110–1121.
Waagepetersen H. S., Qu H., HertZ. L., Sonnewald U. and Schousboe A.
(2002) Demonstration of pyruvate recycling in primary cultures of
neocortical astrocytes but not in neurons. Neurochem. Res. 27,
1431–1437.
Waagepetersen H. S., Sonnewald U., Larsson O. M. and Schousboe A.
(2000a) Compartmentation of TCA cycle metabolism in cultured
neocortical neurons revealed by 13C MR spectroscopy. Neuro-
chem. Int. 36, 349–358.
Waagepetersen H. S., Sonnewald U., Larsson O. M. and Schousboe A.
(2000b) A possible role of alanine for ammonia transfer between
astrocytes and glutamatergic neurons. J. Neurochem. 75, 471–479.
Wang D., Pascual J. M., Yang H., Engelstad K., Jhung S., Sun R. P. and
De Vivo D. C. (2005) Glut)1 deﬁciency syndrome: clinical, gen-
etic, and therapeutic aspects. Ann. Neurol. 57, 111–118.
Yarowsky P., Boyne A. F., Wierwille R. and Brookes N. (1986) Effect of
monensin on deoxyglucose uptake in cultured astrocytes: energy
metabolism is coupled to sodium entry. J. Neurosci. 6, 859–866.
Zwingmann C. and LeibfritZ. D. (2003) Regulation of glial metabolism
studied by 13C-NMR. NMR Biomed 16, 370–399.
Zwingmann C., Richter-Landsberg C., Brand A. and LeibfritZ. D. (2000)
NMR spectroscopic study on the metabolic fate of [3-(13)
C]alanine in astrocytes, neurons, and cocultures: implications for
glia–neuron interactions in neurotransmitter metabolism. Glia 32,
286–303.
Neuron–astrocyte interaction in brain energy 401
 2006 The Authors
Journal Compilation  2006 International Society for Neurochemistry, J. Neurochem. (2006) 99, 393–401
